Advisory Services Network’s ANI Pharmaceuticals ANIP Stock Holding History

Advisory Services Network’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-60	Closed	-$4.61K	–	2270
2026 Q1	$4.61K	Sell	60 -4,000	-99%	-$312K	﹤0.01%	3895
2025 Q4	$320K	Buy	4,060 +60	+2%	+$5.2K	﹤0.01%	1443
2025 Q3	$366K	Buy	+4,000	New	+$326K	0.01%	1354
2019 Q1	–	Sell	-14	Closed	-$1K	–	2513
2018 Q4	$1K	Hold	14	–	–	﹤0.01%	2371
2018 Q3	$1K	Sell	14 -29	-67%	-$1.77K	﹤0.01%	2362
2018 Q2	$3K	Sell	43 -4	-9%	-$250	﹤0.01%	2155
2018 Q1	$3K	Buy	47 +5	+12%	+$317	﹤0.01%	2258
2017 Q4	$3K	Hold	42	–	–	﹤0.01%	2249
2017 Q3	$2K	Hold	42	–	–	﹤0.01%	2121
2017 Q2	$2K	Buy	42 +27	+180%	+$1.3K	﹤0.01%	2076
2017 Q1	$1K	Buy	+15	New	+$842	﹤0.01%	2051
2016 Q3	$13K	Buy	+200	New	+$12.5K	﹤0.01%	1225

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Advisory Services Network's ANIP Position: Q2 2026 in Review

Advisory Services Network sold out of ANI Pharmaceuticals (ANIP) in Q2 2026, closing a stake of 60 shares — an estimated $4.61K sold.

Advisory Services Network first reported a position in ANIP in Q3 2016 and held it in 12 quarters. The position peaked at $366K in Q3 2025. 307 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

Advisory Services Network reported no remaining ANI Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Advisory Services Network sold 60 ANI Pharmaceuticals shares in Q2 2026, an estimated $4.61K.
Advisory Services Network first reported a position in ANI Pharmaceuticals in Q3 2016 and held it in 12 quarters.
Advisory Services Network's ANI Pharmaceuticals position peaked at $366K in Q3 2025.
307 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Advisory Services Network's 13F filing for Q2 2026, filed 12 Aug 2026.